Drug discovery in Africa tackles zoonotic and related infections-Reference-Cited by-同舟云学术

Drug discovery in Africa tackles zoonotic and related infections

Published:2023-10-18 Issue:718 Volume:15 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Hikaambo Christabel N.¹^ORCID,Shakela Natalia¹^ORCID,Woodland John G.¹²³^ORCID,Wicht Kathryn J.¹²³^ORCID,Chibale Kelly¹²³^ORCID

Affiliation:

1. Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, South Africa.

2. Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, Cape Town, South Africa.

3. South African Medical Research Council Drug Discovery and Development Research Unit, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, Cape Town 7701, South Africa.

Abstract

Zoonotic and related infections pose an enormous health threat to the world’s second-most populous continent. Despite the challenges faced by drug discovery scientists in Africa, recent progress toward identifying potential medicines across diverse disease areas is a cause for optimism and an indicator of progress in African-led scientific initiatives.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Link

https://www.science.org/doi/pdf/10.1126/scitranslmed.adj0035

Reference33 articles.

1. WHO. “One health” (2022); www.who.int/news-room/fact-sheets/detail/one-health.

2. WHO. “In Africa 63% jump in diseases spread from animals to people seen in last decade” (2022); www.afro.who.int/news/africa-63-jump-diseases-spread-animals-people-seen-last-decade.

3. Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects

4. Virtual screening and in vitro validation identifies the first reported inhibitors of Salmonella enterica HPPK

5. WHO. “Schistosomiasis” (2023); www.who.int/news-room/fact-sheets/detail/schistosomiasis.